W. Dorr et M. Weberfrisch, REPOPULATION RESPONSE OF MOUSE ORAL-MUCOSA DURING UNCONVENTIONAL RADIOTHERAPY PROTOCOLS, Radiotherapy and oncology, 37(3), 1995, pp. 230-236
Citations number
17
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Repopulation in mouse tongue epithelium was determined during unconven
tional fractionation schedules, i.e., hyperfractionation (2 x 1.5 and
2 x 1.75 Gy/day) and accelerated treatment (2 x 3 Gy/day). The residua
l tolerance of the epithelium at defined days of the fractionated trea
tment was tested by graded single test doses (top-up design). The dose
required to induce complete epithelial denudation in 50% of the anima
ls (ED50) was used to calculate the number of fractions repopulated du
ring the preceding treatment. After the first week of hyperfractionati
on, tolerance was reduced compared to untreated epithelium However, su
bsequently no further change was observed, indicating complete compens
ation of the weekly dose with all doses per fraction used. Epithelial
cell density, defined by histological examination in additional experi
ments, in all fractionation arms decreased similarly by similar to 40%
during the first week and remained constant at 60-80% in the subseque
nt 2 weeks. During accelerated fractionation, the residual mucosal tol
erance decreased continuously with treatment time and resulted in epit
helial denudation after 12 fractions. However, a substantial repopulat
ion effect was observed, compensating 1.5 fractions by day 2, and 5 fr
actions by day 5, respectively. After cessation of the therapy the rep
opulation rate clearly decelerated to compensate a dose equivalent to
about 0.5 fractions per day. Cell density decreased linearly during th
e treatment with 5, 10 or 12 fractions at a rate close to normal cell
loss. Marked cell production, dependent on the total fractionated dose
, was seen from one day after the last fraction in each experimental a
rm. These results indicate that maximum stem cell repopulation occurs
predominantly during treatment, while major production of differentiat
ing cells takes place in treatment splits.